ENLV Stock Price Chart
ENLV Dividends
Enlivex Ltd
$1.84
-4.16%
$-0.07
At close: Aug 12, 16:00:00 GMT-4
$1.91
3.8%
$0.06
Post-market: Aug 12, 20:00:00 GMT-4
Back
Enlivex Ltd (ENLV) Dividends
Key Stats
Prev.Close
$1.92
Open
$2
Day's Range
$1.72 - $2.18
52 week range
$1.8 - $31.5
Volume
643.3K
Avg.Volume
105.6K
Dividend yield
--
EPS (TTM)
149.75
Market Cap
$32.1M
What is ENLV?
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
